| Patent | Date |
|---|
Use Of Anti-fcrn Antibodies In The Treatment Of Pemphighus And Pemphigoid Diseases
App 20220298241 - Blumberg; Laurence J. ; et al. | 2022-09-22 |
Cerdulatinib for treating hematological cancers
Grant 11,446,300 - Coffey , et al. September 20, 2 | 2022-09-20 |
Anti-C5 antibodies having improved pharmacokinetics
Grant 11,434,280 - Andrien, Jr. , et al. September 6, 2 | 2022-09-06 |
Alkaline Phosphatase Polypeptides And Methods Of Use Thereof
App 20220265784 - VOEGTLI; Walter C. ; et al. | 2022-08-25 |
Bis-choline tetrathiomolybdate for treating Wilson Disease
Grant 11,419,832 - Bjartmar , et al. August 23, 2 | 2022-08-23 |
Methods For Treatment Of Refractory Generalized Myasthenia Gravis With Eculizumab
App 20220259305 - Wang; Jing Jing ; et al. | 2022-08-18 |
Inhibitors of protein kinases
Grant 11,414,410 - Bauer , et al. August 16, 2 | 2022-08-16 |
Compositions And Methods For Preparing Factor Xa And Derivatives
App 20220251534 - Lu; Genmin | 2022-08-11 |
Anti-C5A antibodies
Grant 11,407,821 - Rother , et al. August 9, 2 | 2022-08-09 |
Methods for treating craniosynostosis in a patient
Grant 11,400,140 - Saal , et al. August 2, 2 | 2022-08-02 |
Methods for treating lysosomal acid lipase deficiency in patients
Grant 11,400,141 - Quinn August 2, 2 | 2022-08-02 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Atypical Hemolytic Uremic Syndrome (ahus)
App 20220235121 - Payton; Lori ; et al. | 2022-07-28 |
Methods For Treating Lymphoma
App 20220233533 - Coffey; Gregory ; et al. | 2022-07-28 |
Methods Of Treating Vitiligo Using An Anti-c5 Antibody
App 20220227851 - Wells; Richard Alexander | 2022-07-21 |
High concentration anti-C5 antibody formulations
Grant 11,365,241 - Ortiz , et al. June 21, 2 | 2022-06-21 |
Manufacturing of alkaline phosphatases
Grant 11,352,612 - Jaluria , et al. June 7, 2 | 2022-06-07 |
Monovalent Anti-properdin Antibodies And Antibody Fragments
App 20220162292 - SHERIDAN; Douglas L. ; et al. | 2022-05-26 |
Synthesis of cerdulatinib
Grant 11,339,145 - Pandey , et al. May 24, 2 | 2022-05-24 |
Manufacturing Of Glycoproteins
App 20220154155 - GODAWAT; Rahul ; et al. | 2022-05-19 |
Methods For Treating Intracranial Hemorrhage And Assessing Efficacy
App 20220125894 - Yue; Patrick | 2022-04-28 |
Anti-alk2 Antibodies And Uses Thereof
App 20220098310 - Hunter; Jeffrey William ; et al. | 2022-03-31 |
Cerdulatinib For The Treatment Of B-cell Malignancies
App 20220096471 - Pandey; Anjali ; et al. | 2022-03-31 |
Process For Making Recombinant Antidote To Factor Xa Inhibitor
App 20220098565 - Lu; Genmin ; et al. | 2022-03-31 |
Methods For Preparing Ammonium Tetrathiomolybdate
App 20220081387 - Oltner; Viveca ; et al. | 2022-03-17 |
Methods for treating lymphoma
Grant 11,266,645 - Coffey , et al. March 8, 2 | 2022-03-08 |
Bone delivery conjugates and method of using same to target proteins to bone
Grant 11,248,021 - Crine , et al. February 15, 2 | 2022-02-15 |
Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor
Grant 11,244,744 - Bell , et al. February 8, 2 | 2022-02-08 |
Lysosomal acid lipase deficiency compositions and methods
Grant 11,235,036 - Hutchinson , et al. February 1, 2 | 2022-02-01 |
Reduced frequency dosage regimens for tissue non-specific alkaline phosphatase (TNSALP)-enzyme replacement therapy of hypophosphatasia
Grant 11,229,686 - Pradhan , et al. January 25, 2 | 2022-01-25 |
Methods for treating hypophosphatasia (HPP) in adults and adolescents
Grant 11,224,637 - Moseley , et al. January 18, 2 | 2022-01-18 |
Treating seizure with recombinant alkaline phosphatase
Grant 11,224,638 - Marozsan , et al. January 18, 2 | 2022-01-18 |
Fusion Proteins And Methods Of Treating Complement Dysregulation Using The Same
App 20220009979 - Chandler; Julian ; et al. | 2022-01-13 |
Methods For Treatment Of Refractory Generalized Myasthenia Gravis In Pediatric Patients
App 20220002393 - ARMSTRONG; Roisin ; et al. | 2022-01-06 |
Subcutaneous Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Paroxysmal Nocturnal Hemoglobinuria (pnh)
App 20210395352 - Volles; Lori ; et al. | 2021-12-23 |
Methods of treating age-related macular degeneration in a patient comprising administering an anti-C5a antibody
Grant 11,203,634 - Wang , et al. December 21, 2 | 2021-12-21 |
Co-administration Of A Hyaluronidase And Anti-c5 Antibody For Treatment Of Complement-associated Conditions
App 20210388070 - Denker; Andrew ; et al. | 2021-12-16 |
Monovalent anti-properdin antibodies and antibody fragments
Grant 11,198,725 - Sheridan , et al. December 14, 2 | 2021-12-14 |
Inhibition Of Tissue Factor Pathway Inhibitor With Factor Xa Derivatives
App 20210379163 - Lu; Genmin ; et al. | 2021-12-09 |
Antidotes To Factor Xa Inhibitors
App 20210371842 - Conley; Pamela B. ; et al. | 2021-12-02 |
Treating muscle weakness with alkaline phosphatases
Grant 11,186,832 - Marozsan November 30, 2 | 2021-11-30 |
Preparation Of Factor Xa Derivatives
App 20210348149 - Karbarz; Mark ; et al. | 2021-11-11 |
Antidotes For Factor Xa Inhibitors And Methods Of Using The Same
App 20210340515 - Sinha; Uma ; et al. | 2021-11-04 |
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) IN PEDIATRIC PATIENTS
App 20210332147 - PAYTON; Lori ; et al. | 2021-10-28 |
Method of purifying a heterologous protein from an egg white
Grant 11,155,794 - Chen , et al. October 26, 2 | 2021-10-26 |
Manufacturing Of Glycoproteins
App 20210317425 - GODAWAT; Rahul ; et al. | 2021-10-14 |
Lyophilized Formulations For Factor Xa Antidote
App 20210284986 - Wang; Juan ; et al. | 2021-09-16 |
Atypical Hemolytic Uremic Syndrome (ahus) Biomarker Proteins
App 20210285964 - MCKNIGHT; Susan Faas ; et al. | 2021-09-16 |
Methods for treating tracheobronchomalacia
Grant 11,116,821 - Saal September 14, 2 | 2021-09-14 |
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
Grant 11,112,402 - Movalia , et al. September 7, 2 | 2021-09-07 |
Method for simultaneous quantification of ALXN1210 and eculizumab in human serum or urine
Grant 11,112,411 - Chen , et al. September 7, 2 | 2021-09-07 |
Methods of replicating a large scale eculizumab production cell culture
Grant 11,104,726 - Malanson , et al. August 31, 2 | 2021-08-31 |
Antibody Immune Cell Inhibitor Fusion Proteins
App 20210261684 - Chandler; Julian | 2021-08-26 |
Methods For Treatment Of Refractory Generalized Myasthenia Gravis
App 20210246196 - Bedrosian; Camille ; et al. | 2021-08-12 |
Humanized Anti-cd200 Antibodies And Uses Thereof
App 20210230273 - MACK; Taneisha Ann-Tanara ; et al. | 2021-07-29 |
Methods for treating hypophosphatasia in children
Grant 11,065,306 - Fujita , et al. July 20, 2 | 2021-07-20 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Paroxysmal Nocturnal Hemoglobinuria (pnh) In Pediatric Patients
App 20210214425 - PAYTON; Lori ; et al. | 2021-07-15 |
Compositions Comprising An Anti-c5 Antibody
App 20210214427 - WANG; Yi | 2021-07-15 |
Biodegradable Activated Polymers For Therapeutic Delivery
App 20210189062 - CHENG; Christopher J. ; et al. | 2021-06-24 |
Efficacy Of An Anti-c5 Antibody In The Prevention Of Antibody Mediated Rejection In Sensitized Recipients Of Kidney Transplant
App 20210187054 - GRIFFIN; Herman ; et al. | 2021-06-24 |
Methods For Treating Diseases Associated With Ciliopathies
App 20210186985 - SAUNIER; Sophie ; et al. | 2021-06-24 |
Lysosomal Storage Disease Enzymes
App 20210171922 - QUINN; Anthony ; et al. | 2021-06-10 |
Alkaline Phosphatase Polypeptides And Methods Of Use Thereof
App 20210169994 - VOEGTLI; Walter C. ; et al. | 2021-06-10 |
Risk evaluation and management strategy involving patient follow-ups relating to the use or discontinuation of a complement inhibitor
Grant 11,031,102 - Bell , et al. June 8, 2 | 2021-06-08 |
Lyophilized formulations for factor Xa antidote
Grant 11,028,382 - Wang , et al. June 8, 2 | 2021-06-08 |
Methods Of Treating Neurofibromatosis Type 1 And Related Conditions With Alkaline Phosphatase
App 20210162023 - PETRYK; Anna | 2021-06-03 |
Solid Forms Of Cerdulatinib
App 20210130330 - Pandey; Anjali ; et al. | 2021-05-06 |
Methods Of Producing Anti-c5 Antibodies
App 20210122806 - MALANSON; Hunter F. ; et al. | 2021-04-29 |
Method of producing alkaline phosphatase
Grant 10,988,744 - Rajendran , et al. April 27, 2 | 2021-04-27 |
Liquid Formulations Of Anti-cd200 Antibodies
App 20210087267 - MIANO; Dino ; et al. | 2021-03-25 |
Antidotes for factor Xa inhibitors and methods of using the same
Grant 10,954,503 - Sinha , et al. March 23, 2 | 2021-03-23 |
Preparation of factor Xa derivatives
Grant 10,954,504 - Karbarz , et al. March 23, 2 | 2021-03-23 |
Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof
App 20210061890 - MALANSON; Hunter F. ; et al. | 2021-03-04 |
Compositions comprising an anti-C5 antibody
Grant 10,927,166 - Wang February 23, 2 | 2021-02-23 |
High Throughput Method For Measuring The Protease Activity Of Complement C3 Convertase
App 20210025886 - FORBES; Christen D. | 2021-01-28 |
Methods for treating hypophosphatasia in adolescents and adults
Grant 10,898,549 - Fujita , et al. January 26, 2 | 2021-01-26 |
Polypeptides That Bind Complement Component C5 Or Serum Albumin And Fusion Proteins Thereof
App 20200399351 - PUFFER; Bridget ; et al. | 2020-12-24 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20200392216 - BELL; Leonard ; et al. | 2020-12-17 |
Solid forms of cerdulatinib
Grant 10,865,198 - Pandey , et al. December 15, 2 | 2020-12-15 |
Lysosomal storage disease enzymes
Grant 10,858,638 - Quinn , et al. December 8, 2 | 2020-12-08 |
High Concentration Anti-c5 Antibody Formulations
App 20200369751 - ORTIZ; Stephan ; et al. | 2020-11-26 |
Compositions and methods for treating craniosynostosis
Grant 10,822,596 - Hatch November 3, 2 | 2020-11-03 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Generalized Myasthenia Gravis
App 20200331993 - Fujita; Kenji ; et al. | 2020-10-22 |
Methods Of Treating Myointimal Proliferation
App 20200306349 - YAN; Yan ; et al. | 2020-10-01 |
Methods For Treating Hypophosphatasia In Children And Adolescents
App 20200306350 - FUJITA; Kenji ; et al. | 2020-10-01 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Patients With Membranoproliferative Glomerulonephritis
App 20200262897 - REMUZZI; Giuseppe ; et al. | 2020-08-20 |
Methods Of Improving Cardiovascular Function And Treating Cardiovascular Disease Using A Recombinant Ectonucleotide Pyrophosphat
App 20200263153 - KHAN; Tayeba ; et al. | 2020-08-20 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Paroxysmal Nocturnal Hemoglobinuria (pnh) And Atypical Hemolyti
App 20200254092 - Kind Code | 2020-08-13 |
Biomarker Signature For Predicting Tumor Response To Anti-cd200 Therapy
App 20200232990 - JI; Rui-Ru ; et al. | 2020-07-23 |
Metal Impact On Manufacturing Of Alkaline Phosphatases
App 20200224182 - RAJENDRAN; Saravanamoorthy ; et al. | 2020-07-16 |
Methods of shifting an isoelectric profile of a protein product and uses thereof
Grant 10,711,057 - Malanson , et al. | 2020-07-14 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 10,703,809 - Bell , et al. | 2020-07-07 |
Anti-c5a Antibodies
App 20200207842 - ROTHER; Russell P. ; et al. | 2020-07-02 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20200199211 - BELL; Leonard ; et al. | 2020-06-25 |
Methods Of Treating A Subject With An Alkaline Phosphatase Deficiency
App 20200179496 - ODRLJIN; Tatjana | 2020-06-11 |
Methods Of Replicating A Large Scale Eculizumab Production Cell Culture
App 20200172606 - MALANSON; Hunter F. ; et al. | 2020-06-04 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment Of Protein-losing Enteropathy In Patients
App 20200172603 - ADIV; Orly Eshach ; et al. | 2020-06-04 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20200157200 - ANDRIEN, Jr.; Bruce A. ; et al. | 2020-05-21 |
Methods For Treating Complement-associated Disorders
App 20200140531 - ROTHER; Russell P. ; et al. | 2020-05-07 |
N-acetyl-alpha-D-glucosaminidase deficiency compositions and methods
Grant 10,633,705 - Ji , et al. | 2020-04-28 |
Methods For Identifying The Health State Of Hypophosphatasia (hpp) Patients
App 20200121767 - TOMAZOS; Ioannis C. ; et al. | 2020-04-23 |
Efficacy Of An Anti-c5 Antibody In The Prevention Of Antibody Mediated Rejection In Sensitized Recipients Of A Kidney Transplant
App 20200123238 - BEDROSIAN; Camille | 2020-04-23 |
Compositions Comprising An Anti-c5 Antibody
App 20200102379 - WANG; Yi | 2020-04-02 |
Methods For Treating Hypophosphatasia (hpp) In Adults And Adolescents
App 20200101141 - MOSELEY; Scott Edward ; et al. | 2020-04-02 |
Methods of treating a subject with an alkaline phosphatase deficiency
Grant 10,603,361 - Odrljin | 2020-03-31 |
Treating Seizure With Recombinant Alkaline Phosphatase
App 20200093898 - MAROZSAN; Andre ; et al. | 2020-03-26 |
Compositions And Methods For The Treatment Of Neuromyelitis Optica
App 20200095307 - O'Brien; Fanny | 2020-03-26 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 10,590,189 - Bell , et al. | 2020-03-17 |
Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies
Grant 10,584,164 - Andrien, Jr. , et al. | 2020-03-10 |
Methods And Compositions For Treating Complement-associated Disorders
App 20200071391 - Rother; Russell P. | 2020-03-05 |
Compositions and methods relating to genomic modifications in avian primordial germ cells
Grant 10,577,612 - Chang , et al. | 2020-03-03 |
Lysosomal Storage Disease Enzymes
App 20200063113 - Quinn; Anthony ; et al. | 2020-02-27 |
Assay For C5b-9 Deposition In Complement-associated Disorders
App 20200057046 - GALBUSERA; Miriam ; et al. | 2020-02-20 |
Recombinant human ADA2 and ADA2 fusion proteins and methods for treating ADA2 deficiencies
Grant 10,557,161 - Quinn , et al. Feb | 2020-02-11 |
Methods For Reducing Liver Fibrosis And Treating Lysosomal Acid Lipase Deficiency In Patients Based On Ishak Fibrosis Stage
App 20200038491 - QUINN; Anthony ; et al. | 2020-02-06 |
Method For Simultaneous Quantification Of Alxn1210 And Eculizumab In Human Serum Or Urine
App 20200033364 - CHEN; Meng ; et al. | 2020-01-30 |
Methods of replicating a large scale eculizumab production cell culture
Grant 10,544,209 - Malanson , et al. Ja | 2020-01-28 |
Compositions And Methods For Increasing The Serum Half-life Of A Therapeutic Agent Targeting Complement C5
App 20200023060 - Hunter; Jeffrey William ; et al. | 2020-01-23 |
Methods of treating tissue calcification
Grant 10,493,135 - Quinn , et al. De | 2019-12-03 |
Monovalent Anti-properdin Antibodies And Antibody Fragments
App 20190352381 - SHERIDAN; Douglas L. ; et al. | 2019-11-21 |
Compositions comprising an anti-C5 antibody
Grant 10,479,828 - Wang Nov | 2019-11-19 |
Anti-C5a antibodies
Grant 10,450,370 - Rother , et al. Oc | 2019-10-22 |
Treating seizure with recombinant alkaline phosphatase
Grant 10,449,236 - Marozsan , et al. Oc | 2019-10-22 |
Prolongation Of Survival Of An Allograft By Inhibiting Complement Activity
App 20190309053 - ROTHER; Russell P. ; et al. | 2019-10-10 |
Identifying Effective Dosage Regimens For Tissue Non-specific Alkaline Phosphatase (tnsalp)-enzyme Replacement Therapy Of Hypoph
App 20190298810 - PRADHAN; Rajendra ; et al. | 2019-10-03 |
Methods For Treating Lysosomal Acid Lipase Deficiency In Patients
App 20190282671 - Quinn; Anthony | 2019-09-19 |
Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)
Grant 10,413,597 - Quinn , et al. Sept | 2019-09-17 |
Efficacy Of An Anti-c5 Antibody In The Prevention Of Antibody Mediated Rejection In Sensitized Recipients Of A Kidney Transplant
App 20190276524 - GRIFFIN; Herman ; et al. | 2019-09-12 |
Lysosomal storage disease enzymes
Grant 10,407,671 - Quinn , et al. Sept | 2019-09-10 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20190263897 - Andrien, JR.; Bruce A. ; et al. | 2019-08-29 |
A Method Of Quantitating Unbound C5 In A Sample
App 20190250157 - DYSINGER; Mark ; et al. | 2019-08-15 |
A Method Of Quantitating Unbound C5a In A Sample
App 20190242893 - DYSINGER; Mark ; et al. | 2019-08-08 |
A Method For Treating Age-related Macular Degeneration In A Patient
App 20190218278 - Wang; Yi ; et al. | 2019-07-18 |
Methods For Treating Tracheobronchomalacia
App 20190209661 - SAAL; Howard M. | 2019-07-11 |
Polynucleotide Purification With Monolith Columns
App 20190203199 - DAVIS; Jared ; et al. | 2019-07-04 |
Method Of Purifying A Heterologous Protein From An Egg White
App 20190177708 - CHEN; Liang ; et al. | 2019-06-13 |
Lysosomal Acid Lipase Deficiency Compositions And Methods
App 20190151420 - Hutchinson; Andrew ; et al. | 2019-05-23 |
Identifying And Treating Subpopulations Of Paroxysmal Nocturnal Hemoglobinuria (pnh) Patients
App 20190135903 - Bedrosian; Camille | 2019-05-09 |
Bone Delivery Conjugates And Method Of Using Same To Target Proteins To Bone
App 20190119323 - CRINE; Philippe ; et al. | 2019-04-25 |
Treating Muscle Weakness With Alkaline Phosphatases
App 20190119659 - MAROZSAN; Andre | 2019-04-25 |
Methods For Treating Hypophosphatasia In Children
App 20190099473 - FUJITA; Kenji ; et al. | 2019-04-04 |
Compositions Comprising An Anti-c5 Antibody
App 20190092843 - WANG; Yi | 2019-03-28 |
Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
Grant 10,239,937 - Holers , et al. | 2019-03-26 |
Transgene Expression In Avians
App 20190082665 - Harvey; Alex J. ; et al. | 2019-03-21 |
Enzyme Replacement Therapy In Mucopolysaccharidosis Iiib Patients
App 20190083583 - Rojas-Caro; Sandra ; et al. | 2019-03-21 |
Methods of treating atypical hemolytic uremic syndrome with anti-C5 antibodies
Grant 10,227,400 - Andrien, Jr. , et al. | 2019-03-12 |
Methods For Treating Hypophosphatasia In Adolescents And Adults
App 20190060419 - FUJITA; Kenji ; et al. | 2019-02-28 |
Dosage And Administration Of Anti-c5 Antibodies For Treatment
App 20190023775 - BACHMAN; Eric ; et al. | 2019-01-24 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20190025293 - Movalia; Mayur ; et al. | 2019-01-24 |
Method of using a transgenic chicken to produce exogenous proteins in its eggs
Grant 10,182,561 - Harvey , et al. Ja | 2019-01-22 |
T7 Rna Polymerase Variants
App 20190002850 - Miller; Mathew G. ; et al. | 2019-01-03 |
Methods for treating lysosomal acid lipase deficiency in patients
Grant 10,166,274 - Quinn J | 2019-01-01 |
Methods Of Treating A Subject With An Alkaline Phosphatase Deficiency
App 20180333470 - ODRLJIN; Tatjana | 2018-11-22 |
Methods For Treating Craniosynostosis In A Patient
App 20180326017 - SAAL; Howard M. ; et al. | 2018-11-15 |
Compositions Comprising Alkaline Phosphatase And/or Natriuretic Peptide And Methods Of Use Thereof
App 20180326019 - CRINE; Philippe ; et al. | 2018-11-15 |
Compositions comprising an anti-C5 antibody
Grant 10,125,191 - Wang November 13, 2 | 2018-11-13 |
Reagents and methods for detecting PNH type II white blood cells and their identification as risk factors for thrombotic disorders
Grant 10,126,293 - Movalia , et al. November 13, 2 | 2018-11-13 |
Methods Of Treating Tissue Calcification
App 20180318400 - Quinn; Anthony ; et al. | 2018-11-08 |
A Method Of Inhibiting Exacerbations Of T Cell-mediated Allograft Vasculopathy
App 20180311345 - Pober; Jordan ; et al. | 2018-11-01 |
Efficacy Of An Anti-c5 Antibody In The Prevention Of Antibody Mediated Rejection In Sensitized Recipients Of A Kidney Transplant
App 20180311299 - GRIFFIN; Herman ; et al. | 2018-11-01 |
METHODS OF PRODUCING ANTI-C5a ANTIBODIES
App 20180273612 - ROTHER; Russell P. ; et al. | 2018-09-27 |
Egg White Processing
App 20180244716 - CHEN; Liang ; et al. | 2018-08-30 |
Methods Of Treating Adamts13 Deficiencies And Congenital Thrombotic Thrombocytopenia In Pediatric Patients
App 20180237509 - NORIS; Marina ; et al. | 2018-08-23 |
Manufacturing Of Alkaline Phosphatases
App 20180230445 - JALURIA; Pratik ; et al. | 2018-08-16 |
Recombinant Human Ada2 And Ada2 Fusion Proteins And Methods For Treating Ada2 Deficiencies
App 20180201969 - Quinn; Anthony ; et al. | 2018-07-19 |
Therapeutic Compositions Of Alpha-l-iduronidase, Iduronate-2-sulfatase, And Alpha-galactosidase A And Methods Of Use Thereof
App 20180185495 - Heller; Jonathan ; et al. | 2018-07-05 |
Bone delivery conjugates and method of using same to target proteins to bone
Grant 10,000,532 - Crine , et al. June 19, 2 | 2018-06-19 |
Methods, compositions, and kits for the treatment of matrix mineralization disorders
Grant 9,988,620 - Crine , et al. June 5, 2 | 2018-06-05 |
Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof
App 20180148500 - MALANSON; Hunter F. ; et al. | 2018-05-31 |
Method For Treating A Patient In Compliance With Vaccination With Eculizumab Or An Eculizumab Variant
App 20180142010 - BELL; Leonard ; et al. | 2018-05-24 |
Methods of producing anti-C5a antibodies
Grant 9,963,503 - Rother , et al. May 8, 2 | 2018-05-08 |
N-ACETYL-alpha-D-GLUCOSAMINIDASE DEFICIENCY COMPOSITIONS AND METHODS
App 20180105879 - Ji; Rui-Ru ; et al. | 2018-04-19 |
Egg white processing
Grant 9,938,319 - Chen , et al. April 10, 2 | 2018-04-10 |
A Method For Measuring The Protease Activity Of C3 And C5 Convertase Of The Alternative Complement Pathway
App 20180087087 - JOHNSON; Krista K. ; et al. | 2018-03-29 |
Kits comprising formulations of anti-C5 antibodies
Grant 9,925,262 - Zhou , et al. March 27, 2 | 2018-03-27 |
A Method For Measuring The Protease Activity Of Factor D Of The Alternative Complement Pathway
App 20180074077 - JOHNSON; Krista K. ; et al. | 2018-03-15 |
Virus Filtration
App 20180072769 - Olson; Bianca ; et al. | 2018-03-15 |
Producing Therapeutic Proteins
App 20180064136 - Paszek; Adam Albert ; et al. | 2018-03-08 |
Methods of shifting an isoelectric profile of a protein product and uses thereof
Grant 9,908,932 - Malanson , et al. March 6, 2 | 2018-03-06 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20180009885 - ANDRIEN, JR.; Bruce A. ; et al. | 2018-01-11 |
Therapeutic methods using anti-CD200 antibodies
Grant 9,862,767 - Rother , et al. January 9, 2 | 2018-01-09 |
Methods For Treating Complement-associated Disorders
App 20170369562 - ROTHER; Russell P. ; et al. | 2017-12-28 |
Treating Seizure With Recombinant Alkaline Phosphatase
App 20170360899 - MAROZSAN; Andre ; et al. | 2017-12-21 |
Nebulization of Monoclonal Antibodies for Treating Pulmonary Diseases
App 20170355759 - WANG; Yi | 2017-12-14 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20170349652 - BELL; Leonard ; et al. | 2017-12-07 |
Methods for Treatment of Refractory Generalized Myasthenia Gravis
App 20170342139 - Bedrosian; Camille ; et al. | 2017-11-30 |
Lysosomal Storage Disease Enzymes
App 20170314000 - QUINN; ANTHONY ; et al. | 2017-11-02 |
Humaneered anti-factor B antibody
Grant 9,803,005 - Hunter , et al. October 31, 2 | 2017-10-31 |
Anti-C5 antibodies having improved pharmacokinetics
Grant 9,803,007 - Andrien, Jr. , et al. October 31, 2 | 2017-10-31 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20170298123 - ANDRIEN, JR.; Bruce A. ; et al. | 2017-10-19 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20170285013 - MOVALIA; Mayur ; et al. | 2017-10-05 |
Risk Evaluation And Management Strategy Involving Patient Follow-ups Relating To The Use Or Discontinuation Of A Complement Inhibitor
App 20170277835 - BELL; Leonard ; et al. | 2017-09-28 |
Methods for treating complement-associated disorders
Grant 9,771,418 - Rother , et al. September 26, 2 | 2017-09-26 |
Atypical Hemolytic Uremic Syndrome (ahus) Biomarker Proteins
App 20170269102 - McKNIGHT; Susan Faas ; et al. | 2017-09-21 |
Prolongation Of Survival Of An Allograft By Inhibiting Complement Activity
App 20170267751 - ROTHER; Russell P. ; et al. | 2017-09-21 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 9,732,149 - Bell , et al. August 15, 2 | 2017-08-15 |
Transgenic Chickens With An Inactivated Endogenous Gene Locus
App 20170223938 - Van De Lavoir; Marie-Cecile ; et al. | 2017-08-10 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 9,725,504 - Bell , et al. August 8, 2 | 2017-08-08 |
Recombinant Human Naglu Protein And Uses Thereof
App 20170216412 - QUINN; ANTHONY ; et al. | 2017-08-03 |
Methods Of Treating Mucopolysaccharidosis Iiib (mpsiiib)
App 20170216413 - Quinn; Anthony ; et al. | 2017-08-03 |
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
Grant 9,718,880 - Bell , et al. August 1, 2 | 2017-08-01 |
Compositions And Methods For Treating Craniosynostosis
App 20170175094 - HATCH; Nan | 2017-06-22 |
High Concentration Formulations Of Anti-c5 Antibodies
App 20170151328 - ZHOU; Xiao-Hong ; et al. | 2017-06-01 |
Anti-C5 antibodies having improved pharmacokinetics
Grant 9,663,574 - Andrien, Jr. , et al. May 30, 2 | 2017-05-30 |
Npp1 Fusion Proteins
App 20170145393 - QUINN; Anthony ; et al. | 2017-05-25 |
Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
Grant 9,658,236 - McKnight , et al. May 23, 2 | 2017-05-23 |
Recombinant Glycosylated Eculizumab And Eculizumab Variants
App 20170073399 - Andrien; Bruce ; et al. | 2017-03-16 |
Recombinant human NaGlu protein and uses thereof
Grant 9,579,366 - Quinn , et al. February 28, 2 | 2017-02-28 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Grant RE46,323 - Rother , et al. February 28, 2 | 2017-02-28 |
Methods for treating atypical hemolytic uremic syndrome with high concentration formulations of anti-C5 antibodies
Grant 9,556,263 - Zhou , et al. January 31, 2 | 2017-01-31 |
Atypical Hemolytic Uremic Syndrome (ahus) Biomarker Proteins
App 20170023590 - MCKNIGHT; Susan Faas ; et al. | 2017-01-26 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20170015741 - BELL; Leonard ; et al. | 2017-01-19 |
Methods For Treating Complement-associated Disorders
App 20170015740 - Rother; Russell P. ; et al. | 2017-01-19 |
NPP1 fusion proteins
Grant 9,540,621 - Quinn , et al. January 10, 2 | 2017-01-10 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20160376355 - BELL; Leonard ; et al. | 2016-12-29 |
Anti-c5a Antibodies
App 20160376357 - ROTHER; Russell P. ; et al. | 2016-12-29 |
Methods For Treating Complement-associated Disorders
App 20160355579 - Rother; Russell P. ; et al. | 2016-12-08 |
Methods For Treating Complement-associated Disorders
App 20160355580 - ROTHER; Russell P. ; et al. | 2016-12-08 |
Production Of Transgenic Avians Using Improved Retroviral Vectors
App 20160353718 - Harvey; Alex J. ; et al. | 2016-12-08 |
Atypical hemolytic uremic syndrome (AHUS) biomarker proteins
Grant 9,494,601 - McKnight , et al. November 15, 2 | 2016-11-15 |
Antibodies containing therapeutic TPO/EPO mimetic peptides
Grant 9,493,551 - Springhorn , et al. November 15, 2 | 2016-11-15 |
Methods And Compositions For Treating Complement-associated Disorders
App 20160319004 - Rother; Russell P. ; et al. | 2016-11-03 |
Methods of treating complement-associated disorders with anti-C5a antibodies
Grant 9,469,690 - Rother , et al. October 18, 2 | 2016-10-18 |
High Concentration Formulations Of Anti-c5 Antibodies
App 20160272700 - ZHOU; Xiao-Hong ; et al. | 2016-09-22 |
Use of an anti-CD200 antibody for prolonging the survival of allografts
Grant 9,447,187 - Wang , et al. September 20, 2 | 2016-09-20 |
Methods and compositions for treating complement-associated disorders
Grant 9,447,176 - Rother , et al. September 20, 2 | 2016-09-20 |
Nucleic Acids Encodng Anti-c5a Antibodies
App 20160264654 - ROTHER; Russell P. ; et al. | 2016-09-15 |
Nucleic acids encodng anti-C5A antibodies
Grant 9,434,784 - Rother , et al. September 6, 2 | 2016-09-06 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20160251433 - ANDRIEN, JR.; Bruce A. ; et al. | 2016-09-01 |
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
App 20160244516 - BELL; Leonard ; et al. | 2016-08-25 |
High concentration formulations of anti-C5 antibodies
Grant 9,415,102 - Zhou , et al. August 16, 2 | 2016-08-16 |
Methods for treating patients with complement-associated disorders with high concentration formulations of anti-C5 antibodies
Grant 9,409,980 - Zhou , et al. August 9, 2 | 2016-08-09 |
Rationally designed antibodies
Grant 9,409,964 - Bowdish , et al. August 9, 2 | 2016-08-09 |
High Concentration Formulations Of Anti-c5 Antibodies
App 20160215044 - ZHOU; Xiao-Hong ; et al. | 2016-07-28 |
Anti-c5a Antibodies
App 20160207997 - ROTHER; Russell P. ; et al. | 2016-07-21 |
Methods and compositions for the treatment of antibody mediated neuropathies
Grant 9,388,235 - Halstead , et al. July 12, 2 | 2016-07-12 |
Treatment Of Graft Rejection By Administering A Complement Inhibitor To An Organ Prior To Transplant
App 20160184391 - WANG; Yi ; et al. | 2016-06-30 |
Methods Of Purifying Recombinant Proteins
App 20160176921 - Rajendran; Saravanamoorthy ; et al. | 2016-06-23 |
Anti-C5 antibodies having improved pharmacokinetics
Grant 9,371,377 - Andrien, Jr. , et al. June 21, 2 | 2016-06-21 |
Anti-C5a antibodies
Grant 9,371,378 - Rother , et al. June 21, 2 | 2016-06-21 |
Method For Treating A Complement Mediated Disorder Caused By An Infectious Agent In A Patient
App 20160168237 - Fontenot; Darrell ; et al. | 2016-06-16 |
Anti-c5a Antibodies
App 20160159892 - ROTHER; Russell P. ; et al. | 2016-06-09 |
Atypical Hemolytic Uremic Syndrome (ahus) Biomarker Proteins
App 20160154009 - MCKNIGHT; Susan Faas ; et al. | 2016-06-02 |
High concentration antibody formulations
Grant 9,352,035 - Zhou , et al. May 31, 2 | 2016-05-31 |
Risk Evaluation And Management Strategy Involving Patient Follow-ups Relating To The Use Or Discontinuation Of A Complement Inhibitor
App 20160140298 - BELL; Leonard ; et al. | 2016-05-19 |
Methods Of Replicating A Large Scale Eculizumab Production Cell Culture
App 20160108112 - Malanson; Hunter F. ; et al. | 2016-04-21 |
Methods Of Culturing A Cell
App 20160108357 - Malanson; Hunter F. ; et al. | 2016-04-21 |
Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof
App 20160108111 - Malanson; Hunter F. ; et al. | 2016-04-21 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20160108115 - ANDRIEN, JR.; Bruce A. ; et al. | 2016-04-21 |
Nucleic acids encoding anti-C5a antibodies
Grant 9,309,310 - Rother , et al. April 12, 2 | 2016-04-12 |
Bone Delivery Conjugates And Method Of Using Same To Target Proteins To Bone
App 20160052968 - CRINE; Philippe ; et al. | 2016-02-25 |
Compositions And Methods For Increasing The Serum Half-life Of A Therapeutic Agent Targeting Complement C5
App 20160051673 - HUNTER; Jeffrey W. ; et al. | 2016-02-25 |
Nucleic Acides Encoding Anti-c5a Antibodies
App 20160053004 - Rother; Russell P. ; et al. | 2016-02-25 |
Compositions comprising natriuretic peptides and methods of use thereof
Grant 9,266,939 - Crine , et al. February 23, 2 | 2016-02-23 |
Methods for synthesizing molybdopterin precursor Z derivatives
Grant 9,260,462 - Long , et al. February 16, 2 | 2016-02-16 |
Biomarkers Of Immunomodulatory Effects In Humans Treated With Anti-cd200 Antibodies
App 20160033514 - MCKNIGHT; Susan Faas ; et al. | 2016-02-04 |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
Grant 9,249,229 - Bowdish , et al. February 2, 2 | 2016-02-02 |
Therapeutic Methods Using Anti-cd200 Antibodies
App 20160009803 - ROTHER; Russell P. ; et al. | 2016-01-14 |
Methods of treating complement-associated disorders with anti-C5a antibodies
Grant 9,221,901 - Rother , et al. December 29, 2 | 2015-12-29 |
Polypeptides And Antibodies Derived From Chronic Lymphocytic Leukemia Cells And Uses Thereof
App 20150368341 - BOWDISH; Katherine S. ; et al. | 2015-12-24 |
Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics
Grant 9,206,251 - Andrien, Jr. , et al. December 8, 2 | 2015-12-08 |
Biomarkers of immunomodulatory effects in humans treated with anti-CD200 antibodies
Grant 9,180,186 - Faas McKnight , et al. November 10, 2 | 2015-11-10 |
Anti-c5 Antibodies Having Improved Pharmacokinetics
App 20150299305 - ANDRIEN, JR.; Bruce A. ; et al. | 2015-10-22 |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
Grant 9,150,661 - Bowdish , et al. October 6, 2 | 2015-10-06 |
Screening Assays For Complement Component C5 Antagonists
App 20150247849 - Tamburini; Paul P. | 2015-09-03 |
Methods of treating C5 mediated complement-associated conditions with anti-C5 antibodies having improved pharmacokinetics
Grant 9,107,861 - Andrien, Jr. , et al. August 18, 2 | 2015-08-18 |
Humaneered anti-factor B antibody
Grant 9,096,677 - Emlen , et al. August 4, 2 | 2015-08-04 |
Therapeutic methods using anti-CD200 antibodies
Grant 9,085,623 - Rother , et al. July 21, 2 | 2015-07-21 |
Anti-C5 antibodies having improved pharmacokinetics
Grant 9,079,949 - Andrien, Jr. , et al. July 14, 2 | 2015-07-14 |
Anti-c5a Antibodies And Methods For Using The Antibodies
App 20150183859 - ROTHER; Russell P. ; et al. | 2015-07-02 |
Compositions Comprising A Complement Inhibitor And An Interferon Alpha Inhibitor
App 20150174243 - MAGRO; Cynthia | 2015-06-25 |
Humaneered Anti-factor B Antibody
App 20150166643 - Hunter; Jeffrey W. ; et al. | 2015-06-18 |
Anti-C5a antibodies
Grant 9,011,852 - Rother , et al. April 21, 2 | 2015-04-21 |
Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and uses thereof
Grant 8,999,328 - Bowdish , et al. April 7, 2 | 2015-04-07 |
Methods for treating multiorgan, systemic degos' disease with a complement inhibitor
Grant 8,999,340 - Magro April 7, 2 | 2015-04-07 |
Antibodies to OX-2/CD200 and uses thereof
Grant 9,000,133 - Bowdish , et al. April 7, 2 | 2015-04-07 |
Methods and compositions for treating autoimmune disease
Grant 8,986,684 - Wang March 24, 2 | 2015-03-24 |
Atypical Hemolytic Uremic Syndrome Biomarker Proteins
App 20150079613 - MCKNIGHT; Susan Faas ; et al. | 2015-03-19 |
Rationally Designed Antibodies
App 20150004700 - BOWDISH; Katherine S. ; et al. | 2015-01-01 |
Reagents And Methods For Detecting Pnh Type Ii White Blood Cells And Their Identification As Risk Factors For Thrombotic Disorders
App 20140286962 - MOVALIA; Mayur ; et al. | 2014-09-25 |
Methods for treating chronic lymphocytic leukemia
Grant 8,840,885 - Bowdish , et al. September 23, 2 | 2014-09-23 |
Rationally designed antibodies
Grant 8,771,932 - Bowdish , et al. July 8, 2 | 2014-07-08 |
Antibodies to OX-2/CD200 and uses thereof
Grant 8,709,415 - Bowdish , et al. April 29, 2 | 2014-04-29 |
Rationally designed antibodies
Grant 8,674,082 - Bowdish , et al. March 18, 2 | 2014-03-18 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Grant 8,637,014 - Rother , et al. January 28, 2 | 2014-01-28 |
Hybrid antibodies
Grant 8,282,924 - Rother , et al. October 9, 2 | 2012-10-09 |
Antibodies to OX-2/CD200 and uses thereof in inhibiting immune responses
Grant 8,252,285 - Rother , et al. August 28, 2 | 2012-08-28 |
Chronic lymphocytic leukemia cell line
Grant 8,187,877 - Bowdish , et al. May 29, 2 | 2012-05-29 |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
Grant 8,114,403 - Bowdish , et al. February 14, 2 | 2012-02-14 |
Antibodies to OX-2/CD200 and uses thereof
Grant 8,075,884 - Bowdish , et al. December 13, 2 | 2011-12-13 |
Hybrid antibodies
Grant 8,067,167 - Rother , et al. November 29, 2 | 2011-11-29 |
Hybrid antibodies
Grant 7,927,817 - Rother , et al. April 19, 2 | 2011-04-19 |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
Grant 7,915,000 - Bowdish , et al. March 29, 2 | 2011-03-29 |
Phagemid vectors
Grant RE42,130 - Bowdish , et al. February 8, 2 | 2011-02-08 |
| 